These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19306964)

  • 21. [DIGAMI 2: breaking the spell of insulin for heart infarct. Re the article in DMW 45/2004].
    Martin J
    Dtsch Med Wochenschr; 2005 Jan; 130(4):175; author reply 175. PubMed ID: 15714684
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metformin and insulin in chronic heart failure: contraindications not contraindicated and indications not indicated].
    Cosmi F; Cosmi D
    G Ital Cardiol (Rome); 2011 Dec; 12(12):796-803. PubMed ID: 22158450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protecting the heart while controlling blood sugar. New guidelines help define and refine the use of two diabetes drugs that could be a boon for people who also have heart disease.
    Harv Heart Lett; 2004 Mar; 14(7):1. PubMed ID: 15044139
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metformin and kidneys].
    Smahelová A
    Vnitr Lek; 2008 May; 54(5):535-40. PubMed ID: 18630642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin in type 2 diabetes.
    Fox GN
    J Fam Pract; 2004 Nov; 53(11):900. PubMed ID: 15527727
    [No Abstract]   [Full Text] [Related]  

  • 26. Unraveling the association of heart failure from drug and disease: Insights from recent cardiovascular trials in type 2 diabetes mellitus.
    Peters MN; Pollock JS; Rajagopalan S
    J Diabetes Complications; 2016 Mar; 30(2):189-91. PubMed ID: 26632087
    [No Abstract]   [Full Text] [Related]  

  • 27. Metformin and heart failure: never say never again.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2012 Jan; 13(1):1-8. PubMed ID: 22149365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
    Almirall J; Bricullé M; Gonzalez-Clemente JM
    Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk factors for metformin-associated lactic acidosis.
    Beis SJ; Goshman LM; Newkirk GL
    WMJ; 1999; 98(4):56-7. PubMed ID: 10555481
    [No Abstract]   [Full Text] [Related]  

  • 30. The FDA Revises Restrictions on Metformin Use in Kidney Impairment.
    Aschenbrenner DS
    Am J Nurs; 2016 Aug; 116(8):22-3. PubMed ID: 27466921
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventing nephropathy induced by contrast medium.
    Gross JL; Friedman R; Silveiro SP
    N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16641408
    [No Abstract]   [Full Text] [Related]  

  • 32. [Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].
    Pinto D; Heleno B; Gallego R; Santos I; Santiago LM; Maria V
    Acta Med Port; 2011; 24(2):331-8. PubMed ID: 22011607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metformin associated with lactic acidosis in treatment of type 2 diabetes].
    Holst H; Eldrup E; Guldstad NH; Bülow HH; Christensen HR
    Ugeskr Laeger; 2012 Jun; 174(23):1598-602. PubMed ID: 22673379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metformin-associated lactic acidosis can be treated with continuous renal replacement therapy].
    Korvenius Jørgensen H; Nielsen JS; Gilsaa T
    Ugeskr Laeger; 2012 Jun; 174(23):1602-3. PubMed ID: 22673380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How I treat ... with metformin a diabetic patient with moderate renal insufficiency].
    Scheen AJ
    Rev Med Liege; 2013 Apr; 68(4):190-5. PubMed ID: 23755710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metformin and lactic acidosis--fact or fiction? A review of current data].
    Bläuer SC; Keller U
    Praxis (Bern 1994); 2003 Nov; 92(47):2008-10. PubMed ID: 14669502
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 39. Importance of creatinine clearance for drug dosing in nursing home residents.
    Shah J; Fogel J; Balsam L
    Ren Fail; 2014 Feb; 36(1):46-9. PubMed ID: 24111696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pantalone et al.: the risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Bell DS
    Acta Diabetol; 2009 Jun; 46(2):155; author reply 157. PubMed ID: 19300899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.